These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23591723)

  • 1. The role of short daily hemodialysis in the control of hyperphosphatemia, secondary hyperparathyroidism and anemia.
    Jiang JL; Ren W; Li Y; Liu GY; Zhou CP; Su KL; Chen W; Wang K; Ni LJ; Hu Z
    Int Urol Nephrol; 2013 Dec; 45(6):1725-31. PubMed ID: 23591723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of short daily hemodialysis on anemia and the quality of life in Chinese patients.
    Jiang JL; Ren W; Song J; Sun QL; Xiao XY; Diao XZ; Huang YH; Lan L; Wang P; Hu Z
    Braz J Med Biol Res; 2013 Jul; 46(7):629-33. PubMed ID: 23970065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary hyperparathyroidism and anemia. Effects of a calcimimetic on the control of anemia in chronic hemodialysed patients. Pilot Study].
    Mpio I; Boumendjel N; Karaaslan H; Arkouche W; Lenz A; Cardozo C; Cardozo J; Pastural-Thaunat M; Fouque D; Silou J; Attaf D; Laville M
    Nephrol Ther; 2011 Jul; 7(4):229-36. PubMed ID: 21353659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients.
    Wang M; Xiao J; Du Q; Zhang W; Zhang J; Yan Z; Luo J; Yu C; Ye Z; Chen J
    Nephrol Dial Transplant; 2024 Jun; 39(7):1159-1170. PubMed ID: 38037501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral calcium effectively reduces parathyroid hormone levels in hemodialysis patients: a randomized double-blind placebo-controlled study.
    Rudnicki M; Højsted J; Petersen LJ; Sørensen HA; Hyldstrup L; Transbøl I
    Nephron; 1993; 65(3):369-74. PubMed ID: 8289986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
    Rauscher S; Lafrance JP; Pichette V; Bell RZ; Desforges K; Lepage L; Ouellet G; Ouimet D; Leblanc M; Lamarche C; Bezzaoucha S; Vallee M
    Int Urol Nephrol; 2017 Feb; 49(2):325-328. PubMed ID: 27822674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of erythropoietin responsiveness in chronic hemodialysis patients.
    Tonelli M; Blake PG; Muirhead N
    ASAIO J; 2001; 47(1):82-5. PubMed ID: 11199321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease.
    Schwartz DI; Pierratos A; Richardson RM; Fenton SS; Chan CT
    Clin Nephrol; 2005 Mar; 63(3):202-8. PubMed ID: 15786821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis.
    Ting GO; Kjellstrand C; Freitas T; Carrie BJ; Zarghamee S
    Am J Kidney Dis; 2003 Nov; 42(5):1020-35. PubMed ID: 14582046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elderly patients on chronic hemodialysis with hyperparathyroidism: increase of hemoglobin level after intravenous calcitriol.
    Neves PL; Triviño J; Casaubon F; Santos V; Mendes P; Romão P; Bexiga I; Bernardo I
    Int Urol Nephrol; 2006; 38(1):175-7. PubMed ID: 16502078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients.
    Lin CL; Hung CC; Yang CT; Huang CC
    Ren Fail; 2004 May; 26(3):289-95. PubMed ID: 15354979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical self-made device in parathyroid autotransplantation for patients with secondary hyperparathyroidism.
    Du L; Zhang X; Yan L; Zhang H; Tang X; Kong X; Liu G; Huang J
    J Int Med Res; 2019 Jan; 47(1):59-65. PubMed ID: 30198369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease.
    Battistella M; Richardson RM; Bargman JM; Chan CT
    Clin Nephrol; 2011 Aug; 76(2):99-103. PubMed ID: 21762640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Lowering Dialysate Calcium Concentration on Mineral and Bone Disorders in Chronic Hemodialysis Patients: Conversion from 3.0 mEq/L to 2.75 mEq/L.
    Yamada S; Ueki K; Tokumoto M; Suehiro T; Kimura H; Taniguchi M; Fujimi S; Kitazono T; Tsuruya K
    Ther Apher Dial; 2016 Feb; 20(1):31-9. PubMed ID: 26482334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial.
    Wald R; Rabbat CG; Girard L; Garg AX; Tennankore K; Tyrwhitt J; Smyth A; Rathe-Skafel A; Gao P; Mazzetti A; Bosch J; Yan AT; Parfrey P; Manns BJ; Walsh M
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):965-973. PubMed ID: 28550080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage of elevated CaxPO4 product with inflammation in maintenance hemodialysis patients.
    Nasri H
    Minerva Urol Nefrol; 2006 Dec; 58(4):339-45. PubMed ID: 17268399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary hyperparathyroidism among Nigerians with chronic kidney disease.
    Gimba ZM; Abene EE; Agbaji OOO; Agaba EI
    Afr Health Sci; 2018 Jun; 18(2):446-457. PubMed ID: 30602972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.